Chong Li

Principal Investigator

Dr. Chong Li earned his Ph.D. in Human Genetics and Genomics from the University of Miami Miller School of Medicine in the United States in 2018. He then conducted postdoctoral research at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Austria, working in the laboratory of Dr. Jürgen Knoblich. There, he employed stem cell–derived brain organoid systems to investigate human brain development. During this period, he developed CHOOSE—a single-cell functional genomics platform that integrates stem cell engineering, high-throughput genetic screening, and single-cell transcriptomics to quantitatively assess cell type–specific defects associated with neurodevelopmental disorders. In 2024, Dr. Li established his independent laboratory at the Chinese Institute for Brain Research (CIBR) in Beijing, China. His research focuses on uncovering the fundamental principles of human-specific brain development and the molecular mechanisms underlying brain disorders.